Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3275929
Max Phase: Preclinical
Molecular Formula: C70H81N15O16S
Molecular Weight: 1420.57
Molecule Type: Small molecule
Associated Items:
ID: ALA3275929
Max Phase: Preclinical
Molecular Formula: C70H81N15O16S
Molecular Weight: 1420.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
Standard InChI: InChI=1S/C70H81N15O16S/c1-35(2)58(83-60(90)48(12-8-24-75-69(72)73)78-61(91)50(32-56(71)89)82-70(102)77-39-16-21-44(47(28-39)67(97)98)57-45-22-19-42(87)30-54(45)101-55-31-43(88)20-23-46(55)57)64(94)79-49(26-38-14-17-41(86)18-15-38)62(92)84-59(36(3)4)65(95)80-51(29-40-33-74-34-76-40)66(96)85-25-9-13-53(85)63(93)81-52(68(99)100)27-37-10-6-5-7-11-37/h5-7,10-11,14-23,28,30-31,33-36,48-53,58-59,86-87H,8-9,12-13,24-27,29,32H2,1-4H3,(H2,71,89)(H,74,76)(H,78,91)(H,79,94)(H,80,95)(H,81,93)(H,83,90)(H,84,92)(H,97,98)(H,99,100)(H4,72,73,75)(H2,77,82,102)/t48-,49-,50-,51-,52-,53-,58-,59-/m0/s1
Standard InChI Key: VBDQGKSIUJDVTH-BFKOBUQJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1420.57 | Molecular Weight (Monoisotopic): 1419.5706 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Galardy RE, Stafford SS, Schaefer ML, Ho H, La Vorgna KA, Jamieson JD.. (1978) Biologically active derivatives of angiotensin for labeling cellular receptors., 21 (12): [PMID:214560] [10.1021/jm00210a020] |
Source(1):